Fosaprepitant Dimeglumine

Common brands: Emend, Dexamethasone 1.5 Mg, Ozurdex, Dexamethasone, Dextenza

Top reporter: Merck Sharp & Dohme Llc

Substance P/Neurokinin-1 Receptor Antagonist [EPC]Corticosteroid [EPC]Platinum-based Drug [EPC]Serotonin-3 Receptor Antagonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
13,499
Total Reports
5,164
Serious Reports
2,187
Death Reports
30
Reported Reactions
Death Report Ratio: High (16.20%)

Patient Demographics

Male
4,607
Female
7,719

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Fosaprepitant Dimeglumine.

# Reaction Reports % of Total
1 NAUSEA 1,457
6.5%
2 DYSPNOEA 1,239
5.5%
3 PYREXIA 1,103
4.9%
4 DIARRHOEA 1,096
4.9%
5 VOMITING 1,064
4.7%
6 FATIGUE 1,055
4.7%
7 OFF LABEL USE 877
3.9%
8 ALOPECIA 862
3.8%
9 RASH 840
3.7%
10 HYPERSENSITIVITY 815
3.6%
11 FEBRILE NEUTROPENIA 805
3.6%
12 PRURITUS 721
3.2%
13 INFUSION RELATED REACTION 715
3.2%
14 STOMATITIS 657
2.9%
15 PAIN 634
2.8%
16 GENERAL PHYSICAL HEALTH DETERIORATION 630
2.8%
17 CONFUSIONAL STATE 615
2.7%
18 DECREASED APPETITE 610
2.7%
19 INFECTION 598
2.7%
20 ARTHRALGIA 592
2.6%
21 HEPATIC ENZYME INCREASED 586
2.6%
22 ASTHENIA 572
2.5%
23 MALAISE 563
2.5%
24 GASTROINTESTINAL DISORDER 561
2.5%
25 INSOMNIA 549
2.4%
26 IMPAIRED HEALING 546
2.4%
27 ABDOMINAL DISCOMFORT 545
2.4%
28 GLOSSODYNIA 536
2.4%
29 WEIGHT INCREASED 536
2.4%
30 FOLLICULITIS 529
2.4%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.